tirzepatide spotting Mounjaro and Post-Menopausal Bleeding: UK Medical Guidance – Bolt Pharmacy Medscape | Patients treated with

Remember that sustainable weight management is a journey, not a destination

The satiety effects diminish

For individuals with PCOS or insulin resistance, the body may not respond as effectively to GLP-1 medications, leading to less noticeable results

The FDA has not evaluated the specific compounded formulation for safety, effectiveness, or quality as a finished product

Ongoing monitoring should include thyroid function testing at appropriate intervals, particularly in patients experiencing significant weight loss or after tirzepatide dose increases

Jens Aberle from the University Medical Center Hamburg-Eppendorf to illustrate this